Mirae Asset Global Investments Co., Ltd. Recursion Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 12,721 shares of RXRX stock, worth $92,227. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,721
Previous 87,539
85.47%
Holding current value
$92,227
Previous $576,000
85.24%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RXRX
# of Institutions
299Shares Held
241MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$235 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$180 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$176 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$125 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$112 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.31B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...